Capricor Therapeutics
CAPR
#5371
Rank
A$2.09 B
Marketcap
A$36.14
Share price
-2.61%
Change (1 day)
69.37%
Change (1 year)

Earnings for Capricor Therapeutics (CAPR)

Earnings in 2025 (TTM): -A$0.17 Billion

According to Capricor Therapeutics 's latest financial reports the company's current earnings are N/A. a decrease over its 2024 earnings that were of -A$57.74 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Capricor Therapeutics from 2001 to 2025

Annual earnings

Year Earnings Change
2025 -A$0.15 Billion159.57%
2024 -A$57.74 Million81.57%
2023 -A$31.8 Million-23.2%
2022 -A$41.41 Million44.93%
2021 -A$28.57 Million46.61%
2020 -A$19.49 Million78.71%
2019 -A$10.91 Million-49.7%
2018 -A$21.68 Million-724.78%
2017 A$3.46 M-112.93%
2016 -A$26.84 Million46.27%
2015 -A$18.35 Million106.82%
2014 -A$8.87 Million-48.41%
2013 -A$17.2 Million977.23%
2012 -A$1.6 Million-77.11%
2011 -A$6.98 Million-22.35%
2010 -A$8.98 Million-20.17%
2009 -A$11.25 Million-41.17%
2008 -A$19.12 Million41.05%
2007 -A$13.56 Million1098.87%
2006 -A$1.14 Million4101.55%
2005 -A$0.03 Million-0.97%
2004 -A$0.03 Million17.87%
2003 -A$0.03 Million3.66%
2002 -A$0.03 Million-30.11%
2001 -A$0.04 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
A$37.06 B-24,832.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
A$1.13 B-860.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Cytokinetics
CYTK
-A$1.19 Billion 689.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-A$0.42 Billion 173.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
-A$6.85 Million-95.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-A$13.54 Million-90.97%๐Ÿ‡บ๐Ÿ‡ธ USA